Society guideline links: Myasthenia gravis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Thymomas and thymic carcinomas".)

Links to guidelines related to coronavirus disease 2019 (COVID-19) are also provided separately. (See "Society guideline links: COVID-19 – Index of guideline topics".)

International

●International consensus guidance for management of myasthenia gravis, 2020 update (published 2021)

•International consensus guidance for the management of myasthenia gravis (2016)

Canada

●National Advisory Committee on Blood and Blood Products (NAC) and Canadian Blood Services (CBS): Guidelines on the use of intravenous immune globulin for neurologic conditions (2007)

United States

●American Academy of Neurology (AAN): Practice advisory – Thymectomy for myasthenia gravis (practice parameter update) (2020, reaffirmed 2023)

●American Association of Electrodiagnostic Medicine (AAEM): Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome – Summary statement (reaffirmed 2015)

●American Association of Neuroscience Nurses (AANN): Care of the patient with myasthenia gravis (2013)

●American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM): Consensus statement – The use of intravenous immunoglobulin in the treatment of neuromuscular conditions (2009)

Europe

●European Federation of Neurological Societies (EFNS)/European Neurological Society (ENS): Guidelines for the treatment of ocular myasthenia (2014)

●EFNS: Guidelines for treatment of autoimmune neuromuscular transmission disorders (2010)

●EFNS: Guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases (2008)

United Kingdom

●Association of British Neurologists (ABN): Management guidelines on myasthenia gravis (2015)

●Myasthenia in pregnancy – Best practice guidelines from a UK multispecialty working group (2014)

Japan

●[In Japanese] Japanese Association of Rehabilitation Medicine (JARM): Japanese guidelines for pulmonary rehabilitation of neuromuscular disease and spinal cord injury, 1st edition (2014)

●[In Japanese] Japanese Society of Neurology (JSN): Guidelines for the treatment of myasthenia gravis (2014)